FI772823A - Nya 1-aryloxi-hydroxi-3-alkylenaminopropaner och foerfarande foer deras framstaellning - Google Patents

Nya 1-aryloxi-hydroxi-3-alkylenaminopropaner och foerfarande foer deras framstaellning

Info

Publication number
FI772823A
FI772823A FI772823A FI772823A FI772823A FI 772823 A FI772823 A FI 772823A FI 772823 A FI772823 A FI 772823A FI 772823 A FI772823 A FI 772823A FI 772823 A FI772823 A FI 772823A
Authority
FI
Finland
Prior art keywords
alkylenaminopropaner
aryloxi
hydroxi
nya
foerfarande foer
Prior art date
Application number
FI772823A
Other languages
English (en)
Other versions
FI69066B (fi
FI69066C (fi
Inventor
Herbert Koeppe
Anton Mentrup
Ernst-Otto Renth
Kurt Schromm
Wolfgang Hoefke
Gojko Muacevic
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI772823A publication Critical patent/FI772823A/fi
Priority to FI822062A priority Critical patent/FI822062A0/fi
Publication of FI69066B publication Critical patent/FI69066B/fi
Application granted granted Critical
Publication of FI69066C publication Critical patent/FI69066C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
FI772823A 1976-10-05 1977-09-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-aryloxi-2-hydroxi-3-alkylenaminopropaner samt deras fysiologiskt laempliga syraadditionssalter FI69066C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI822062A FI822062A0 (fi) 1976-10-05 1982-06-10 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-aryloxi-hydroxi-3-alkylenaminopropaner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2644833 1976-10-05
DE19762644833 DE2644833A1 (de) 1976-10-05 1976-10-05 Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
FI772823A true FI772823A (fi) 1978-04-06
FI69066B FI69066B (fi) 1985-08-30
FI69066C FI69066C (fi) 1985-12-10

Family

ID=5989679

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772823A FI69066C (fi) 1976-10-05 1977-09-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-aryloxi-2-hydroxi-3-alkylenaminopropaner samt deras fysiologiskt laempliga syraadditionssalter

Country Status (33)

Country Link
US (7) US4256756A (fi)
JP (1) JPS5368775A (fi)
AT (15) AT361908B (fi)
AU (1) AU514600B2 (fi)
BE (1) BE859415A (fi)
BG (1) BG33153A3 (fi)
CA (4) CA1101859A (fi)
CS (1) CS197304B2 (fi)
DD (5) DD148051A5 (fi)
DE (1) DE2644833A1 (fi)
DK (1) DK439077A (fi)
ES (16) ES462868A1 (fi)
FI (1) FI69066C (fi)
FR (1) FR2394534A1 (fi)
GB (3) GB1592975A (fi)
GR (1) GR64229B (fi)
HK (1) HK19385A (fi)
HU (1) HU177173B (fi)
IE (3) IE46158B1 (fi)
IL (1) IL53043A (fi)
LU (1) LU78240A1 (fi)
MY (1) MY8500909A (fi)
NL (1) NL7710840A (fi)
NO (1) NO151411C (fi)
NZ (1) NZ185356A (fi)
PH (4) PH15763A (fi)
PL (1) PL113879B1 (fi)
PT (1) PT67107B (fi)
SE (1) SE442400B (fi)
SG (1) SG70884G (fi)
SU (1) SU665801A3 (fi)
YU (1) YU40484B (fi)
ZA (1) ZA775905B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
SE8003277L (sv) * 1979-05-04 1980-11-05 Continental Pharma Bensimidazolderivat, deras framstellning och anvendning samt kompositioner innehallande dessa derivat
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
US4379508A (en) * 1981-10-14 1983-04-12 Nestier Corporation Nesting tray with stacking keyed interlock
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) * 1983-07-09 1985-01-17 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (fi) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6860524B1 (en) 1993-05-14 2005-03-01 William W. Rowley Polyolefin connectors
US6557907B2 (en) 1993-05-14 2003-05-06 William W. Rowley Polyethylene connectors
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6848719B2 (en) 2001-09-06 2005-02-01 William W. Rowley Bendable polymer-lined water heater connector
AR042132A1 (es) * 2002-11-26 2005-06-08 Smithkline Beecham Corp Compuesto de 2- hidroxi -3-(2- aril - 1, 1 - dimetiletilamino) propoxifenilo, composicion farmaceutica que lo comprende y uso del mismo para prepararla
EP1575923A2 (en) * 2002-12-23 2005-09-21 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST &bgr;-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP1833480A2 (en) * 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US8993641B2 (en) * 2007-11-29 2015-03-31 Innolex Investment Corporation Preservation of cosmetics, toiletry and pharmaceutical compositions
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284529A (fi) * 1961-10-24
GB1066613A (en) * 1965-03-03 1967-04-26 Ici Ltd Naphthalene derivatives
GB1349358A (en) * 1969-11-28 1974-04-03 Teikoku Hormone Mfg Co Ltd Hydrogenation process
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3818017A (en) * 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) * 1973-07-18 1976-11-24 Ici Ltd Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (fi) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
LU78240A1 (fi) 1979-02-02
FI69066B (fi) 1985-08-30
ES462868A1 (es) 1978-12-16
JPS5368775A (en) 1978-06-19
ATA679377A (de) 1980-09-15
ATA57580A (de) 1980-12-15
ES471806A1 (es) 1979-02-01
ATA57280A (de) 1980-10-15
NO151411B (no) 1984-12-27
PL113879B1 (en) 1981-01-31
IE46160B1 (en) 1983-03-09
HK19385A (en) 1985-03-22
ES471805A1 (es) 1979-02-01
ATA57880A (de) 1980-10-15
IL53043A (en) 1982-01-31
CA1127643A (en) 1982-07-13
ES471801A1 (es) 1979-02-01
DK439077A (da) 1978-04-06
AU514600B2 (en) 1981-02-19
SE7711168L (sv) 1978-05-18
FR2394534B1 (fi) 1982-04-30
FI69066C (fi) 1985-12-10
PH18363A (en) 1985-06-13
DD148051A5 (de) 1981-05-06
DD148050A5 (de) 1981-05-06
CS197304B2 (en) 1980-04-30
ES471807A1 (es) 1979-02-01
DD134642A5 (de) 1979-03-14
ATA58080A (de) 1981-04-15
ES471795A1 (es) 1979-02-01
US4296117A (en) 1981-10-20
AT361914B (de) 1981-04-10
ES471794A1 (es) 1979-02-01
US4256756A (en) 1981-03-17
ES471797A1 (es) 1979-02-01
US4343800A (en) 1982-08-10
ATA56780A (de) 1980-09-15
ES471796A1 (es) 1979-02-01
MY8500909A (en) 1985-12-31
ES471808A1 (es) 1979-02-01
GB1592975A (en) 1981-07-15
SG70884G (en) 1985-04-04
AT362364B (de) 1981-05-11
BG33153A3 (en) 1982-12-15
ATA57480A (de) 1980-10-15
ATA57680A (de) 1980-12-15
ATA57180A (de) 1980-09-15
IE822409L (en) 1978-04-05
AT362362B (de) 1981-05-11
NL7710840A (nl) 1978-04-07
IE46158L (en) 1978-04-05
ES471798A1 (es) 1979-02-01
US4381309A (en) 1983-04-26
AT363082B (de) 1981-07-10
ES471803A1 (es) 1979-02-01
SE442400B (sv) 1985-12-23
JPS6210988B2 (fi) 1987-03-10
AU2933377A (en) 1979-04-12
IE822410L (en) 1978-04-05
ATA57380A (de) 1980-10-15
ATA57080A (de) 1980-09-15
IL53043A0 (en) 1977-12-30
DE2644833A1 (de) 1978-04-20
BE859415A (fr) 1978-04-05
AT362365B (de) 1981-05-11
ES471804A1 (es) 1979-02-01
AT361915B (de) 1981-04-10
NO151411C (no) 1985-04-10
AT361911B (de) 1981-04-10
AT363081B (de) 1981-07-10
PH16053A (en) 1983-06-09
GB1592976A (en) 1981-07-15
US4604468A (en) 1986-08-05
AT363079B (de) 1981-07-10
ATA56980A (de) 1980-09-15
AT361913B (de) 1981-04-10
ES471800A1 (es) 1979-02-01
PT67107B (de) 1980-04-07
AT361912B (de) 1981-04-10
IE46159B1 (en) 1983-03-09
ES471799A1 (es) 1979-02-01
NO773384L (no) 1978-04-06
AT361908B (de) 1981-04-10
ATA56880A (de) 1980-09-15
PH19028A (en) 1985-12-06
AT362363B (de) 1981-05-11
AT364828B (de) 1981-11-25
PL201286A1 (pl) 1978-12-04
ES471802A1 (es) 1979-02-01
DD143074A5 (de) 1980-07-30
NZ185356A (en) 1981-05-01
ZA775905B (en) 1979-06-27
ATA57780A (de) 1980-12-15
FR2394534A1 (fr) 1979-01-12
PH15763A (en) 1983-03-22
DD148052A5 (de) 1981-05-06
HU177173B (en) 1981-08-28
AT363080B (de) 1981-07-10
YU40484B (en) 1986-02-28
ATA57980A (de) 1980-12-15
US4255430A (en) 1981-03-10
IE46158B1 (en) 1983-03-09
GB1592977A (en) 1981-07-15
CA1126271A (en) 1982-06-22
CA1125751A (en) 1982-06-15
YU236977A (en) 1983-01-21
CA1101859A (en) 1981-05-26
GR64229B (en) 1980-02-14
US4212877A (en) 1980-07-15
SU665801A3 (ru) 1979-05-30
PT67107A (de) 1977-11-01

Similar Documents

Publication Publication Date Title
FI771951A (fi) Nya halosporinderivat
FI780801A (fi) Nya cefem- och cefam-kompositioner och foerfarande foer deras framstaellning
FI772778A (fi) Portabla och foeraenderliga vaeggsystem
FI773870A (fi) Handskfoerpackning och aemne foer densamma
FI772823A (fi) Nya 1-aryloxi-hydroxi-3-alkylenaminopropaner och foerfarande foer deras framstaellning
FI773558A (fi) Skeppsbottenfaerg och liknande
FI773031A (fi) Haollbara aeggprodukter och foerfarande foer deras framstaellning
SE7707734L (sv) Nya hydroxi-succinimido-estrar
FI773519A (fi) Flotationsfoerfarande och uppsamlingskomposition
FI773804A (fi) Nya nukleosider och foerfarande foer deras framstaellning
FI772262A (fi) Nya fenyletylaminer och foerfarande foer deras framstaellning
FI773219A (fi) Projektil saerskilt foer handelvapen och laongpipiga vapen
FI773801A (fi) Hydroxamsyror och foerfarande foer deras framstaellning
FI773768A (fi) Luggtextilfoeremaol och foerfarande foer deras framstaellning
FI783590A (fi) Nya prostacyklinderivat och foerfarande foer deras framstaellning
FI773954A (fi) Steroliner och deras anvaendning
FI772453A (fi) Dihydro-oxo-nikotinsyror och foerfarande foer deras framstaellning
SE7712387L (sv) Nya morfantridiner
FI782215A (fi) Nya nitrosoureafoereningar och deras framstaellningsfoerfarande
FI780083A (fi) Nya ditienylalkylaminer och foerfarande foer deras framstaellning
FI773822A (fi) Antitumoerglykosider och foerfarande foer framstaellning daerav
FI772921A (fi) Nya kortekoider
FI772394A (fi) Nya behensyraestrar
FI783769A (fi) Nya tetrapeptider och metoder
FI772833A (fi) Nya hydroxi-metyl-pyridinestrar och foerfarande foer deras framstaellning

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: C.H. BOEHRINGER SOHN